Free Trial
→ Ticker Revealed: Pre-IPO Access to 'Next Elon Musk' Company (From Banyan Hill Publishing) (Ad)tc pixel Free CRDL Stock Alerts

Cardiol Therapeutics (CRDL) Competitors

Cardiol Therapeutics logo
C$1.80 -0.02 (-1.10%)
As of 04:00 PM Eastern
Compare

CRDL vs. TEV, NOT, PYR, NVO, and DNA

Should you be buying Cardiol Therapeutics stock or one of its competitors? The main competitors of Cardiol Therapeutics include Tervita (TEV), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), and Dalradian Resources (DNA). These companies are all part of the "pharmaceutical products" industry.

How does Cardiol Therapeutics compare to Tervita?

Tervita (TSE:TEV) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, institutional ownership, media sentiment, valuation, earnings, analyst recommendations, risk and profitability.

In the previous week, Tervita's average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
Tervita Neutral
Cardiol Therapeutics Neutral

Tervita has higher revenue and earnings than Cardiol Therapeutics. Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Tervita, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TervitaC$1.36B0.00-C$1.04M-C$0.01N/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A

Tervita's return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
TervitaN/A N/A N/A
Cardiol Therapeutics N/A -238.02%-54.15%

0.1% of Cardiol Therapeutics shares are owned by institutional investors. 4.6% of Cardiol Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Tervita beats Cardiol Therapeutics on 5 of the 8 factors compared between the two stocks.

How does Cardiol Therapeutics compare to Noront Resources?

Noront Resources (CVE:NOT) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

In the previous week, Noront Resources' average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
Noront Resources Neutral
Cardiol Therapeutics Neutral

Noront Resources is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Noront ResourcesN/AN/AN/A-C$0.15N/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A

Noront Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Noront ResourcesN/A N/A N/A
Cardiol Therapeutics N/A -238.02%-54.15%

0.1% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Noront Resources and Cardiol Therapeutics tied by winning 3 of the 6 factors compared between the two stocks.

How does Cardiol Therapeutics compare to PyroGenesis Canada Inc. (PYR.V)?

PyroGenesis Canada Inc. (PYR.V) (CVE:PYR) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

In the previous week, PyroGenesis Canada Inc. (PYR.V) had 2 more articles in the media than Cardiol Therapeutics. MarketBeat recorded 2 mentions for PyroGenesis Canada Inc. (PYR.V) and 0 mentions for Cardiol Therapeutics. PyroGenesis Canada Inc. (PYR.V)'s average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
PyroGenesis Canada Inc. (PYR.V) Neutral
Cardiol Therapeutics Neutral

PyroGenesis Canada Inc. (PYR.V) has higher revenue and earnings than Cardiol Therapeutics. PyroGenesis Canada Inc. (PYR.V) is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PyroGenesis Canada Inc. (PYR.V)C$6.01M100.97-C$3.94M-C$0.03N/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A

PyroGenesis Canada Inc. (PYR.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
PyroGenesis Canada Inc. (PYR.V)N/A N/A N/A
Cardiol Therapeutics N/A -238.02%-54.15%

0.1% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

PyroGenesis Canada Inc. (PYR.V) beats Cardiol Therapeutics on 6 of the 9 factors compared between the two stocks.

How does Cardiol Therapeutics compare to Novo Resources Corp. (NVO.V)?

Novo Resources Corp. (NVO.V) (CVE:NVO) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.

0.1% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Novo Resources Corp. (NVO.V)'s average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
Novo Resources Corp. (NVO.V) Neutral
Cardiol Therapeutics Neutral

Novo Resources Corp. (NVO.V) is trading at a lower price-to-earnings ratio than Cardiol Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Novo Resources Corp. (NVO.V)N/AN/AN/A-C$0.11N/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A

Novo Resources Corp. (NVO.V)'s return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Novo Resources Corp. (NVO.V)N/A N/A N/A
Cardiol Therapeutics N/A -238.02%-54.15%

Summary

Novo Resources Corp. (NVO.V) and Cardiol Therapeutics tied by winning 3 of the 6 factors compared between the two stocks.

How does Cardiol Therapeutics compare to Dalradian Resources?

Dalradian Resources (TSE:DNA) and Cardiol Therapeutics (TSE:CRDL) are both small-cap pharmaceutical products companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

0.1% of Cardiol Therapeutics shares are held by institutional investors. 4.6% of Cardiol Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, Dalradian Resources' average media sentiment score of 0.00 equaled Cardiol Therapeutics'average media sentiment score.

Company Overall Sentiment
Dalradian Resources Neutral
Cardiol Therapeutics Neutral

Cardiol Therapeutics is trading at a lower price-to-earnings ratio than Dalradian Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dalradian ResourcesN/AN/AN/A-C$0.03N/A
Cardiol TherapeuticsN/AN/A-C$42.93M-C$0.39N/A

Dalradian Resources' return on equity of 0.00% beat Cardiol Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Dalradian ResourcesN/A N/A N/A
Cardiol Therapeutics N/A -238.02%-54.15%

Summary

Dalradian Resources and Cardiol Therapeutics tied by winning 3 of the 6 factors compared between the two stocks.

Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRDL vs. The Competition

Export
MetricCardiol TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$201.02MC$1.63BC$6.24BC$11.72B
Dividend YieldN/A2.97%2.73%6.22%
P/E Ratio-4.624.1829.0423.83
Price / SalesN/A1,488.53477.1013.46
Price / Cash0.9810.3727.6282.69
Price / Book10.0910.729.674.48
Net Income-C$42.93MC$21.15BC$3.55BC$300.68M
7 Day Performance-3.23%-1.16%1.70%0.12%
1 Month Performance-9.09%0.17%5.62%2.88%
1 Year Performance13.21%24.19%34.42%57.78%

Cardiol Therapeutics Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRDL
Cardiol Therapeutics
N/AC$1.80
-1.1%		N/AN/AC$201.02MN/AN/A20
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36BN/A36,800
NOT
Noront Resources
N/AC$1.10
-0.5%		N/AN/AC$612.18MN/AN/A101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%		N/AN/AC$606.96MC$6.01MN/A90
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%		N/AN/AC$548.24MN/AN/A54,400

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (TSE:CRDL) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
URGENT: $2 Gold Stock With Major Discovery
A $2 gold stock is said to quietly control what may be the largest gold deposit in the world - worth nearly $1...
Paradigm Press | Sponsoredtc pixel